Neuphoria Therapeutics Q4'26 EPS estimate seen at (0.56) USD
Neuphoria Therapeutics is set to announce Q4'26 results on September 02, with results expected at 8:00 AM ET. Q4'26 revenue estimate is 0 USD, and EPS is anticipated at (0.56) USD.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.